Koninklijke Philips EBITDA 2010-2025 | PHG

Koninklijke Philips annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Koninklijke Philips EBITDA for the quarter ending March 31, 2025 was $0.454B, a 3778.53% increase year-over-year.
  • Koninklijke Philips EBITDA for the twelve months ending March 31, 2025 was $0.949B, a 25.12% increase year-over-year.
  • Koninklijke Philips 2024 annual EBITDA was $2.077B, a 66.26% increase from 2023.
  • Koninklijke Philips 2023 annual EBITDA was $1.249B, a 17.16% decline from 2022.
  • Koninklijke Philips 2022 annual EBITDA was $1.508B, a 32.61% decline from 2021.
Koninklijke Philips Annual EBITDA
(Millions of US $)
2024 $2,077
2023 $1,249
2022 $1,508
2021 $2,237
2020 $3,662
2019 $3,521
2018 $3,316
2017 $2,890
2016 $3,517
2015 $2,577
2014 $2,252
2013 $4,487
2012 $3,186
2011 $3,471
2010 $4,530
2009 $2,823
Koninklijke Philips Quarterly EBITDA
(Millions of US $)
2025-03-31 $454
2024-06-30 $879
2023-06-30 $242
2023-03-31 $-626
2022-06-30 $12
2021-06-30 $102
2020-06-30 $252
2019-06-30 $392
2018-06-30 $355
2017-06-30 $278
2016-12-31 $1,287
2016-09-30 $867
2016-06-30 $776
2016-03-31 $587
2015-12-31 $618
2015-09-30 $733
2015-06-30 $750
2015-03-31 $476
2014-12-31 $368
2014-09-30 $275
2014-06-30 $870
2014-03-31 $739
2013-12-31 $1,544
2013-09-30 $1,067
2013-06-30 $1,069
2013-03-31 $807
2012-12-31 $652
2012-09-30 $1,166
2012-06-30 $638
2012-03-31 $1,037
2011-12-31 $601
2011-09-30 $623
2011-06-30 $864
2011-03-31 $1,267
2010-12-31 $1,532
2010-09-30 $1,099
2010-06-30 $924
2010-03-31 $994
2009-12-31 $2,828
2009-09-30 $1,047
2009-06-30 $-658
2009-03-31 $181
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $21.694B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.294B 27.81
Boston Scientific (BSX) United States $157.073B 39.32
Stryker (SYK) United States $146.485B 30.63
EssilorLuxottica (ESLOY) France $131.510B 0.00
Medtronic (MDT) Ireland $104.117B 14.76
Haleon (HLN) United Kingdom $50.587B 28.80
Lonza Group Ag (LZAGY) Switzerland $49.544B 0.00
ResMed (RMD) United States $36.103B 27.12
GE HealthCare Technologies (GEHC) United States $32.514B 15.44
Agilent Technologies (A) United States $31.721B 20.95
Terumo (TRUMY) Japan $28.131B 36.54
Insulet (PODD) United States $22.987B 90.23
Zimmer Biomet Holdings (ZBH) United States $18.639B 11.97
Baxter (BAX) United States $15.842B 11.83
Smith & Nephew SNATS (SNN) United Kingdom $12.666B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.269B 21.81
Lantheus Holdings (LNTH) United States $5.242B 13.22
Prestige Consumer Healthcare (PBH) United States $4.244B 18.96
Perrigo (PRGO) Ireland $3.757B 9.52
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.266B 14.88
ICU Medical (ICUI) United States $3.210B 23.67
Envista Holdings (NVST) United States $3.051B 25.35
GN Store Nord (GNNDY) Denmark $2.163B 17.92
QuidelOrtho (QDEL) United States $2.114B 14.54
LeMaitre Vascular (LMAT) United States $1.868B 41.76
AtriCure (ATRC) United States $1.683B 0.00
Neogen (NEOG) United States $1.335B 17.08
Acuren (TIC) United States $1.317B 0.00
AdaptHealth (AHCO) United States $1.256B 12.75
Kestra Medical Technologies (KMTS) United States $1.156B 0.00
Green Thumb Industries (GTBIF) United States $1.120B 25.19
BioLife Solutions (BLFS) United States $1.057B 0.00
Phibro Animal Health (PAHC) United States $0.991B 12.67
InMode (INMD) Israel $0.919B 9.26
Evolus (EOLS) United States $0.633B 0.00
CeriBell (CBLL) United States $0.625B 0.00
Curaleaf Holdings (CURLF) Canada $0.590B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.568B 0.00
Valneva SE (VALN) France $0.534B 0.00
Owens & Minor (OMI) United States $0.509B 4.22
Capricor Therapeutics (CAPR) United States $0.479B 0.00
Tilray Brands (TLRY) Canada $0.446B 0.00
Surmodics (SRDX) United States $0.412B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.339B 0.00
Cresco Labs (CRLBF) United States $0.324B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.86
Canopy Growth (CGC) Canada $0.313B 0.00
Aurora Cannabis (ACB) Canada $0.307B 54.70
Sanara MedTech (SMTI) United States $0.274B 0.00
Viemed Healthcare (VMD) United States $0.261B 22.00
ZimVie (ZIMV) United States $0.245B 11.11
Cerus (CERS) United States $0.241B 0.00
Sanuwave Health (SNWV) United States $0.239B 0.00
Verano Holdings (VRNOF) United States $0.237B 0.00
Biote (BTMD) United States $0.223B 6.28
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
OraSure Technologies (OSUR) United States $0.207B 0.00
Brainsway (BWAY) Israel $0.201B 53.25
Quanterix (QTRX) United States $0.197B 0.00
Omeros (OMER) United States $0.186B 0.00
High Tide (HITI) Canada $0.185B 0.00
Organigram Global (OGI) Canada $0.179B 0.00
Utah Medical Products (UTMD) United States $0.178B 14.46
Exagen (XGN) United States $0.145B 0.00
FitLife Brands (FTLF) United States $0.136B 16.69
Jin Medical (ZJYL) China $0.124B 0.00
TerrAscend (TSNDF) Canada $0.114B 0.00
MacroGenics (MGNX) United States $0.094B 0.00
Agape ATP (ATPC) $0.092B 0.00
Fonar (FONR) United States $0.089B 11.42
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Zynex (ZYXI) United States $0.078B 0.00
Quipt Home Medical (QIPT) United States $0.076B 0.00
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.071B 0.00
Apyx Medical (APYX) United States $0.067B 0.00
Jushi Holdings (JUSHF) United States $0.060B 0.00
ImmuCell (ICCC) United States $0.056B 0.00
United Health Products (UEEC) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
Modular Medical (MODD) United States $0.047B 0.00
United-Guardian (UG) United States $0.039B 13.47
Rockwell Medical (RMTI) United States $0.033B 0.00
Nephros (NEPH) United States $0.031B 41.86
Safety Shot (SHOT) United States $0.029B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00